Flonase Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Funding
• Alerts
• Clinical Trials
• Forums

Bioequivalence Study of Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS ® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Conditions:   Bioequivalence;   Asthma Interventions:   Drug: Test;   Drug: Reference Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 20, 2021 Category: Research Source Type: clinical trials